Employees Provident Fund Board’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41M | Buy |
163,093
+17,959
| +12% | +$3.86M | 0.24% | 50 |
|
|
2026
Q1 | $31.6M | Buy |
145,134
+134
| +0.1% | +$29.7K | 0.24% | 48 |
|
|
2025
Q4 | $33.1M | Hold |
145,000
| – | – | 0.24% | 50 |
|
|
2025
Q3 | $33.6M | Buy |
145,000
+14,956
| +12% | +$3.05M | 0.27% | 50 |
|
|
2025
Q2 | $24.1M | Buy |
130,044
+28,544
| +28% | +$5.3M | 0.21% | 59 |
|
|
2025
Q1 | $21.3M | Buy |
101,500
+58,500
| +136% | +$11.4M | 0.24% | 59 |
|
|
2024
Q4 | $7.64M | Sell |
43,000
-7,000
| -14% | -$1.29M | 0.09% | 75 |
|
|
2024
Q3 | $9.87M | Hold |
50,000
| – | – | 0.14% | 74 |
|
|
2024
Q2 | $8.58M | Buy |
50,000
+2,000
| +4% | +$331K | 0.14% | 73 |
|
|
2024
Q1 | $8.74M | Sell |
48,000
-2,400
| -5% | -$414K | 0.15% | 67 |
|
|
2023
Q4 | $7.81M | Buy |
50,400
+1,400
| +3% | +$204K | 0.15% | 61 |
|
|
2023
Q3 | $7.3M | Buy |
49,000
+50
| +0.1% | +$7.34K | 0.17% | 63 |
|
|
2023
Q2 | $6.6M | Buy |
+48,950
| New | +$7.18M | 0.16% | 66 |
|
|
2021
Q1 | – | Sell |
-36,450
| Closed | -$3.91M | – | 65 |
|
|
2020
Q4 | $3.91M | Hold |
36,450
| – | – | 0.07% | 67 |
|
|
2020
Q3 | $3.19M | Sell |
36,450
-2,339
| -6% | -$220K | 0.07% | 61 |
|
|
2020
Q2 | $3.81M | Buy |
+38,789
| New | +$3.42M | 0.09% | 59 |
|
|
2017
Q2 | – | Sell |
-98,673
| Closed | -$6.43M | – | 51 |
|
|
2017
Q1 | $6.43M | Sell |
98,673
-155,022
| -61% | -$9.75M | 0.19% | 51 |
|
|
2016
Q4 | $15.9M | Buy |
253,695
+113,247
| +81% | +$6.91M | 0.54% | 37 |
|
|
2016
Q3 | $8.86M | Hold |
140,448
| – | – | 0.32% | 39 |
|
|
2016
Q2 | $8.7M | Sell |
140,448
-163,094
| -54% | -$9.94M | 0.37% | 32 |
|
|
2016
Q1 | $17.3M | Sell |
303,542
-202,070
| -40% | -$11.3M | 0.74% | 30 |
|
|
2015
Q4 | $30M | Sell |
505,612
-721,488
| -59% | -$41.6M | 1.02% | 30 |
|
|
2015
Q3 | $57.7M | Buy |
1,227,100
+610,467
| +99% | +$39.7M | 2.19% | 20 |
|
|
2015
Q2 | $41.4M | Sell |
616,633
-132,967
| -18% | -$8.68M | 1.45% | 28 |
|
|
2015
Q1 | $43.9M | Sell |
749,600
-59,244
| -7% | -$3.58M | 1.49% | 27 |
|
|
2014
Q4 | $52.9M | Buy |
808,844
+261,295
| +48% | +$16.5M | 1.62% | 25 |
|
|
2014
Q3 | $31.6M | Sell |
547,549
-77,503
| -12% | -$4.3M | 1% | 37 |
|
|
2014
Q2 | $35.3M | Buy |
625,052
+125,052
| +25% | +$6.56M | 1.11% | 33 |
|
|
2014
Q1 | $24.6M | Hold |
500,000
| – | – | 0.79% | 36 |
|
|
2013
Q4 | $26.4M | Sell |
500,000
-15,630
| -3% | -$768K | 0.8% | 36 |
|
|
2013
Q3 | $23.1M | Hold |
515,630
| – | – | 0.83% | 36 |
|
|
2013
Q2 | $21.3M | Buy |
+515,630
| New | +$22.6M | 0.86% | 34 |
|
Other funds holding ABBV
Employees Provident Fund Board's ABBV Position: Q2 2026 in Review
Employees Provident Fund Board increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $3.86M and bringing the position to 163,093 shares worth $41M. The position accounts for 0.24% of the portfolio, ranked #50.
Employees Provident Fund Board first reported a position in ABBV in Q2 2013 and has held it in 32 quarters since. The position peaked at $57.7M in Q3 2015. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Employees Provident Fund Board held 163,093 shares of AbbVie worth $41M as of Q2 2026.
- Employees Provident Fund Board bought 17,959 AbbVie shares in Q2 2026, an estimated $3.86M.
- AbbVie made up 0.24% of Employees Provident Fund Board's portfolio in Q2 2026, its #50 holding.
- Employees Provident Fund Board first reported a position in AbbVie in Q2 2013 and has held it in 32 quarters since.
- Employees Provident Fund Board's AbbVie position peaked at $57.7M in Q3 2015.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.